Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Edscharp who wrote (297)	3/20/1999 1:39:00 PM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 3044

Edward, here is another link from this thread (cites a story from the Financial Times): Message 5981990 There was also a short but "meaty" article that appeared in The Economist about the same time (October), shortly after the Bayer deal. As for buy/hold etc., of course, it's hard to tell. In the absence of further news, it's hard for me to see significant short term upside from the current levels. Yet, these guys have surprised more than once with their creative deal making backed with strong science and technology base. I have to give them the old "hairy eye ball" if they were to drop under 30 again, which most likely they will. PB (with apologies to MB for borrowing his "heb" term -g-)